Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

British Journal of Cancer

Volumn 35, Issue 1, 1977, Pages 1-39

  Peto, R ^a   Pike, M C ^b   Armitage, P ^a   Breslow, N E ^c   Cox, D R ^d   Howard, S V ^e   Mantel, N ^f   McPherson, K ^a   Peto, J ^a   Smith, P G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c University of Seattle ^*  (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER THERAPY; CAUSE OF DEATH; CLINICAL TRIAL; DEMOGRAPHY; FATALITY; FOLLOW UP; LIFE TABLE; METHODOLOGY; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL RATE; THERAPY;

DRUG EVALUATION; HUMANS; LEUKEMIA; METHODS; MORTALITY; MULTIPLE MYELOMA; PROGNOSIS; REMISSION, SPONTANEOUS; RESEARCH DESIGN; STATISTICS; TIME FACTORS;

EID: 0017365573     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1977.1     Document Type: Article

References (18)

1. Armitage, P. & Gehan, E. A. (1974) Statistical Methods for the Identification and use of Prognostic factors. Int. J. Cancer, 13, 16.
2. Breslow, N. E. (1975) Analysis of Survival Data under the Proportional Hazards Model. Int. statist. Rev., 43, 45.
3. Cox, D. R. (1972) Regression Models and Life Tables (with discussion). J. R. statist. Soc., B, 34, 187.
4. Gehan, E. A. (1965) A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-censored Samples. Biometrika, 52, 203.
5. Heyn, R. M., Joo, P., Karon, M., Nesbit, M., Shore, N., Breslow, N., Weiner, J., Reed, A. & Hammond, D. (1975) BCG in the Treatment of Acute Lymphocytic Leukaemia. Blood, 46, 431.
6. Kaplan, E. L., Meier, P. (1958) Nonparametric Estimation from Incomplete Observations. J. Am. statist. Ass., 53, 457.
7. Mantel, N. (1966) Evaluation of Survival Data and Two New Rank Order Statistics Arising in its Consideration. Cancer Chemother. Rep., 50, 163.
8. MATHE, G., AMIEL, J., SCHWARZENBEBG, L., SCHNEIDER, M., CATTAN, A., SCHLUMBEBGER, J. R., HAY AT, M., DE VASSAL, F. (1969) Active Immunotherapy for Acute Lymphoblastic Leukaemia. Lancet, 1, 697.
9. Medical Research Council (1968) Chronic Granulocytic Leukaemia: Comparison of Radiotherapy and Busulphan Therapy. Br. med. J., 1, 201.
10. Medical Research Council (1971a) Myelomatosis: Comparison of Melphalan and Cyclophosphamide Therapy. Br. med. J., 1 640.
11. Medical Research Council (1971) Treatment of Acute Lymphoblastic Leukaemia. Br. med. J., 4, 189.
12. Medical Research Council (1973) Report on the First Myelomatosis Trial. Br. J. Haemat., 24, 123.
13. Medical Research Council (1974) Treatment of Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercap top urine, L-aspara- ginase. Prednisone and Thioguanine: Results of Treatment with Five Multi-drug Schedules. Br. J. Haemat., 27, 373.
14. Peto, R. (1972) Rank Tests of Maximal Power against Lehmann-tvpe Alternatives. Biometrika, 59, 472.
15. Peto, R. & Peto, J. (1972) Asymptotically Efficient Rank Invariant Test Procedures (with discussion). J. R. statist. Soc., A, 135, 185.
16. Peto, R. & Pike, M. C. (1973) Conservatism of the Approximation E(0-E)*/E in the Logrank Test for Survival Data or Tumor Incidence Data. Biometrics, 29, 579.
17. Pike, M. C. (1973) The Analysis of Clinical Trials in Leukaemia. In Recent Results in Cancer Research, 43, Ed. G. Mathe, P. Pouillant, and L. Schwarzen- berg. New York: Springer-Verlag.
18. Zelen, M. (1973) Keynote Address on Biostatistics and Data Retrieval. Cancer Chemother. Rep., 4, 31.